Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuroimaging of Bupropion Add-on in Major Depressive Disorder
NCT01541475Phase 4Completed
- Sponsor
- Ewha Womans University
- Start
- Mar 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupropion in major depressive disorder (MDD), sponsored by Ewha Womans University. Primary endpoint: Change from Baseline in Depressive Symptom Scores at 8 weeks. Started Mar 2009; status: completed.
02
Drugs
bupropion
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01541475.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01541475.